Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents
NCT ID: NCT05380765
Last Updated: 2024-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-06-17
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tailored Interventions to Prevent Substance Abuse
NCT01482975
Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group
NCT05363878
Culturally Grounded Early Substance Use Prevention for American Indian Families
NCT02383225
Substance Use Prevention for Youth With Parents in Recovery
NCT05397691
Strategies: Motivational Interviewing/Psychoeducation
NCT03458299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Native PATHS Condition
A strengths-based, behavioral economic approach to increasing engagement and reinforcement for engaging in alternative activities.
Native PATHS
A strengths-based, behavioral economic approach to increasing engagement and reinforcement for engaging in alternative activities.
Wait-List Control
Participants will receive the Native PATHS program once 6-month follow up surveys have been completed.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Native PATHS
A strengths-based, behavioral economic approach to increasing engagement and reinforcement for engaging in alternative activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. identify as a member of a First Nation,
3. be in grades 5th - 8th at time of enrollment, and
4. one youth per household may participate.
1. at least 18 years of age
2. reside within the First Nation community
3. be identified, by the youth, as an important influence in their life
4. be committed to helping the youth make good decisions regarding using substances
10 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rhode Island
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nichea S Spillane, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Rhode Island
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rhode Island
Kingston, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.